Abstract:B76 Measurements of parameters such as apparent diffusion coefficient (ADC) of water and tissue Na + by magnetic resonance (MR) techniques have been suggested as noninvasive methods for predicting and/or monitoring response to therapy (1, 2). We and others have found that effective chemotherapy of subcutaneously (sc) implanted Radiation Induced Fibrosarcome (RIF-1) in mice with cyclophosphamide (1) and 5-fluorouracil (3), as well as, chemotherapy of intracranial 9L glioma in rats with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) (1) correlate with increases in both total tumor tissue 23 Na signal intensity (SI) and water ADC in the first 3-5 post-treatment days. The most frequently cited hypothesis explaining an increase in tumor water ADC and 23 Na SI following therapy is that tumor cell death by apoptosis or necrosis invoke a net increase in extracellular space (ECS), an environment of assumed fast-diffusing water and high [Na + ] (1, 4). However, this clarification does not explain our results of BCNU treatment of sc-implanted 9L glioma. We have found that in sc-implanted 9L glioma 23 Na SI and water ADC significantly increase with growth in untreated control and non-responsive glioma, while in BCNU-responsive glioma both 23 Na SI and water ADC were almost unchanged (5). It appears the increase in water ADC and 23 Na SI after chemotherapy is not general phenomena resulting from an increase in ECS. Furthermore, in sc-implanted 9L glioma, Winter et al. (6) did not find any changes in the relative ECS, explaining the lower [Na + ] t in BCNU-treated tumors by improvement of tumor oxygenation and perfusion. We hypothesized that the different results in sc-implanted and intracranial glioma could be caused by location of tumors. However, Schepkin et al. recently reported the increase in water ADC and 23 Na SI in sc-implanted 9L glioma treated by BNCU (7). We assumed that the source of cell culture can play a role in different effects of BCNU. In our study, we used 9L cells from American Type Culture Collection (ATCC), while others (1, 7) used 9L cells from Brain Tumor Research Center, UCSF. Our preliminary results show a one week delay in the sc-growth of 9L glioma from ATCC compared to the tumor growth initiated by cells from UCSF. Additional estimation should be done to evaluate the possible role of type of anesthesia and tumor size in efficiency of BCNU treatment in experimental 9L glioma.References: (1) Schepkin et al. MRM, 53: 85-92, 2005; (2) Babsky et al. Neoplasia, 7: 658-66, 2005; (3) Babsky et al. ISMRM, p.1767, 2006; (4) Ross et al. Eur J Cancer, 38: 2147-56, 2002; (5) Babsky et al. JMRI, 24: 132-9, 2006; (6) Winter et al. Cancer Res 61: 2002-7, 2001; (7) Schepkin et al. MRI, 24: 273-8, 2006.

Biom-17. Evaluation Of Carbonic Anhydrase Type Ix (Ca Ix) Expression As Target For Radioligand Therapy In Glioblastoma

Targeting CAIX with [64Cu]xyimsr-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice

Pet Imaging Of Carbonic Anhydrase Ix Expression Of Ht-29 Tumor Xenograft Mice With Ga-68-Labeled Benzenesulfonamides

Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells

TARGETING HYPOXIA DOWNSTREAM SIGNALING PROTEIN, CAIX FOR CAR-T CELL THERAPY AGAINST GLIOBLASTOMA (GBM)

Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX

Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy

Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9

Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells

Imaging of Carbonic Anhydrase IX with an 111In-Labeled Dual-Motif Inhibitor

Application of carbonic anhydrase IX in sporadic hemangioblastoma of the central nervous system and hemangioblastoma associated with von Hippel-Lindau disease

Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy

Abstract 4206: A Dual-Motif CAIX Inhibitor, [64Cu]xyimsr-06, for PET Imaging of Clear Cell Renal Cell Carcinoma

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models

A Dual-Motif Caix Inhibitor, [64cu]Xyimsr-06, For Pet Imaging Of Clear Cell Renal Cell Carcinoma

Fluorine-18 click radiosynthesis and MicroPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX

High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX

The Problems of Monitoring Response to Chemotherapy in Subcutaneously Implanted 9L Glioma Using Apparent Diffusion Coefficient of Water and 23na Magnetic Resonance Imaging

Exth-25. Optimization Of New Chemotherapeutic Agents By Intra-Arterial Infusion In Glioblastomas

Targeted Radiolabeled Compounds in Glioma Therapy

Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography.